Page 5 of 9
Organic & Biomolecular Chemistry
through a pad of Celite and rinsed successively with DCM.
The combined filtrate (~150 mL) was washed with sat. aq.
NaHCO3 (3 x 40 mL). The layers were separated, and the
aqueous phase was extracted with dichloromethane (2 x
150 mL). The combined organic phase was dried with
magnesium sulfate and concentrated under reduced
pressure. The residue was purified by column
chromatography on silica gel (ethyl acetate - hexane
gradient elution) to give ethyl 2,3-di-O-benzyl-4-O-p-
methoxybenzyl-1-thio-β-D-glucopyranoside 20 in 79%
yield (3.51 g, 6.68 mmol). Analytical data for 20: Rf = 0.45
= 4.3 Hz, J5,6b = 4.4 Hz, 1H, H-5), 3.97D(dOdI:,1J03.,140=399/D.10HOBz0, 018H0,3HF -
3), 3.61 (dd, J2,3 = 8.9 Hz, 1H, H-2), 2.89 – 2.65 (m, 2H,
SCH2CH3), 1.29 (t, J = 7.4 Hz, 3H, SCH2CH3) ppm; 13C NMR (75
MHz, CDCl3): δ 164.6, 164.3, 150.1, 150.0, 147.7, 147.4,
137.9, 137.8, 137.2, 137.1, 128.6 (x3), 128.4 (x2), 128.2
(x2), 128.1 (x2), 127.8, 127.3, 127.1, 125.9, 125.6, 85.4, 83.7,
81.7, 75.9, 75.8, 75.5, 71.9, 64.3, 25.2, 15.3 ppm; HRMS
[M+Na]+ calcd for C34H34N2O7SNa 637.1984 found 637.1988.
Ethyl
2-O-benzyl-3,4,6-tri-O-picoloyl-1-thio-α-D-
mannopyranoside (23). p-Toluenesulfonic acid (3.1 mg,
0.016 mmol) and ethanethiol (12.3 mg, 0.198 mmol) were
added to a solution of ethyl 2-O-benzyl-4,6-O-benzylidene-
3-picoloyl-1-thio-α-D-mannopyranoside18 (33, 16.6 mg,
0.033 mmol) in DCM (0.5 mL), and the resulting solution
was stirred under argon for 2 h at rt. The reaction mixture
was then neutralized with triethylamine, the volatiles were
removed under reduced pressure, and the residue
containing ethyl 2-O-benzyl-1-thio-α-D-mannopyranoside
(34) was dried in vacuo for 2 h. The title compound was
then obtained from crude 34 (0.033 mmol) in
dichloromethane (0.5 mL), picolinic acid (24.6 mg, 0.198
mmol), EDC (38.0 mg, 0.198 mmol), and DMAP (0.81 mg,
0.007 mmol) in accordance with the general procedure as a
white amorphous solid in 86% yield (17.7 mg, 0.028 mmol).
Analytical data for 23: Rf = 0.4 (acetone/toluene, 1/1, v/v);
25
(ethyl acetate/hexane, 3/2, v/v); [α]D -32.5 (c = 1.86,
CHCl3); 1H NMR (300 MHz, CDCl3): δ 7.50 – 7.19 (m, 12H,
2
aromatic), 6.87 (d, 2H, aromatic), 4.85 (dd, J = 9.4 Hz, 2H,
CH2Ph), 4.83 (dd, 2J = 10.2 Hz, 2H, CH2Ph), 4.50 (s, 2H,
CH2Ph), 4.48 (d, J1,2 = 9.7 Hz, 1H, H-1), 3.80 (s, 3H, OCH3),
3.71 (d, 1H, H-6a), 3.70 (d, 1H, H-6b), 3.62 (dd, J4,5 = 9.1 Hz,
1H, H-4), 3.51 (dd, J3,4 = 8.6 Hz, 1H, H-3), 3.44 (dd, J5,6a = J5,6b
= 4.8 Hz, 1H, H-5), 3.40 (dd, J2,3 = 9.0 Hz, 1H, H-2), 2.87 – 2.62
(m, 2H, SCH2CH3), 1.32 (t, J = 7.4 Hz, 3H, SCH2CH3) ppm; 13
C
NMR (75 MHz, CDCl3): δ 159.5, 138.7, 138.1, 130.0, 129.6,
128.8, 128.6 (x2), 128.2, 128.1 (x2), 114.0, 86.2, 85.3, 81.4,
77.9, 75.7, 75.6, 73.5, 72.5, 70.6, 55.5, 25.3, 15.4 ppm; HRMS
[M+Na]+ calcd for C30H36O6SNa 547.2125 found 547.2131.
Compound 19 was prepared from 20 (1.48 g, 2.83 mmol) in
CH2Cl2 (50 mL), picolinic acid (0.701 g, 5.65 mmol), EDC
(1.08 g, 5.65 mmol), and DMAP (0.069 g, 0.57 mmol) in
21
1
[α]D +52.5 (c = 2.0, CHCl3); H NMR (300 MHz, CDCl3): δ
8.70 (d, 3H, aromatic), 8.17 – 7.95 (m, 3H, aromatic), 7.84 –
7.66 (m, 3H, aromatic), 7.51 – 7.38 (m, 3H, aromatic), 7.38 –
7.25 (m, 2H, aromatic), 7.25 – 7.10 (m, 3H, aromatic), 6.17
(dd, J4,5 = 10.0 Hz, 1H, H-4), 5.70 (dd, J3,4 = 10.0 Hz, 1H, H-3),
5.51 (dd, 1H, H-1), 4.87 (dd, 1H, H-5), 4.68 (dd, 2J = 12.0 Hz,
2H, CH2Ph), 4.67-4.64 (m, 2H, H-6a, 6b), 4.27 (dd, J2,3 = 1.5
Hz, 1H, H-2), 2.84 – 2.47 (m, 2H, SCH2CH3), 1.29 (t, J = 7.4 Hz,
3H, SCH2CH3) ppm; 13C NMR (75 MHz, CDCl3): δ 164.5, 164.0,
163.7, 150.2, 150.1 (x2), 147.6, 147.1, 147.0, 137.5, 137.2
(x2), 137.1, 128.4 (x2), 127.9 (x3), 127.3, 127.1, 126.9,
125.7, 125.6, 125.4, 82.0, 77.1, 73.1, 72.8, 68.8, 68.3, 64.0,
25.4, 14.9 ppm; HRMS [M+Na]+ calcd for C33H31N3O8SNa
652.1724 found 652.1738.
accordance with the general procedure as
a white
amorphous solid in 97% yield (1.72 g, 2.74 mmol).
Analytical data for 19: Rf = 0.55 (acetone/ hexane, 1/1, v/v);
24
1
[α]D -27.6 (c = 1.0, CHCl3); H NMR (300 MHz, CDCl3): δ
8.78 – 8.69 (m, 1H, aromatic), 7.98 (m, 1H, aromatic), 7.78
(m, 1H, aromatic), 7.46 (m, 1H, aromatic), 7.41 – 7.24 (m,
5H, aromatic), 7.18 – 7.02 (m, 7H, aromatic), 6.77 – 6.66 (m,
2H, aromatic), 5.37 (dd, J4,5 = 9.7 Hz, 1H, H-4), 4.84 (dd, 2J =
10.2 Hz, 2H, CH2Ph), 4.73 (dd, 2J = 11.2 Hz, 2H, CH2Ph), 4.55
(d, J1,2 = 9.8 Hz, 1H, H-1), 4.39 (dd, 2H, H-6a, 6b), 3.90 (dd,
J3,4 = 9.1 Hz, 1H, H-3), 3.82 (dd, 1H, H-5), 3.73 (s, 3H, OCH3),
2
3.60 (dd, J = 4.4 Hz, 2H, CH2Ph), 3.56 (dd, J2,3 = 8.9 Hz, 1H,
H-2), 2.89 – 2.69 (m, 2H, SCH2CH3), 1.34 (t, J = 7.4 Hz, 3H,
SCH2CH3) ppm; 13C NMR (75 MHz, CDCl3): δ 164.3, 159.1,
145.0, 147.7, 138.1, 138.0, 137.1, 130.1, 129.5 (x2), 128.6
(x4), 128.3 (x2), 128.1 (x3), 127.7, 127.1, 125.7, 113.7, 85.3,
83.8, 81.8, 77.4, 75.8, 75.6, 73.3, 72.5, 69.5, 55.3 (x2), 25.2,
15.4 ppm; HRMS [M+Na]+ calcd for C36H39NO7SNa 652.2345
found 652.2347.
Selective Deprotection of the Pico group
General procedure for Pico removal. Iron(III) chloride
(0.017 mmol) or copper(II) acetate (0.017 mmol) was
added to a solution of a Pico derivative (0.051 mmol) in
MeOH-DCM (1.0 mL, 1.0/1, v/v), and the resulting mixture
was stirred under argon at rt. Upon completion (see the
reaction time listed in Scheme 1), the volatiles were
removed under reduced pressure. The residue was diluted
with DCM (~5 mL) and washed with sat. aq. NaHCO3 (5 mL)
and water (2 x 5 mL). The organic phase was separated,
dried using magnesium sulfate, filtered and concentrated
under reduced pressure. The residue was purified by
column chromatography on silica gel (ethyl acetate –
hexane gradient elution) to give the corresponding
deprotected derivative in yields listed in Scheme 1.
Ethyl
2,3-di-O-benzyl-4,6-di-O-picoloyl-1-thio-β-D-
glucopyranoside (21). The title compound was prepared
from ethyl 2,3-di-O-benzyl-1-thio-β-D-glucopyranoside45
(22, 237.3 mg, 0.59 mmol) in CH2Cl2 (10 mL), picolinic acid
(364.0 mg, 2.90 mmol), EDC (555.9 mg, 2.90 mmol), and
DMAP (36.1 mg, 0.30 mmol) in accordance with the general
procedure as a white amorphous solid in 86% yield (311.1
mg, 0.51 mmol). Analytical data for 21: Rf
= 0.30
(acetone/hexane, 1/3, v/v); [α]D24 -6.40 (c = 1.0, CHCl3); 1H
NMR (300 MHz, CDCl3): δ 8.77 – 8.64 (m, 2H, aromatic), 8.15
– 8.06 (m, 1H, aromatic), 8.06 – 7.98 (m, 1H, aromatic), 7.86
– 7.74 (m, 2H, aromatic), 7.52 – 7.29 (m, 7H, aromatic), 7.08
(s, 5H, aromatic), 5.52 (dd, J4,5 = 9.8 Hz, 1H, H-4), 4.85 (dd, 2J
= 10.2 Hz, 2H, CH2Ph), 4.76 (dd, 2J = 11.2 Hz, 2H, CH2Ph),4.61
(d, J1,2 = 9.8 Hz, 1H, H-1), 4.56 (d, 2H, H-6a, 6b), 4.06 (dd, J5,6a
Ethyl
(2). The title compound was obtained from ethyl 2,3,6-tri-
O-benzyl-4-O-picoloyl-1-thio-β-D-glucopyranoside16
(1,
2,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside
29.1 mg, 0.052 mmol) and iron(III) trichloride (2.5 mg,
0.016 mmol) in methanol (0.9 mL) and dichloromethane
(0.1 mL) in accordance with the general procedure as a
colorless syrup in 5 h in 91% yield (23.3 mg, 0.047 mmol).